New directions for biologic targets in urothelial carcinoma--letter

Mol Cancer Ther. 2012 Oct;11(10):2306; author reply 2307. doi: 10.1158/1535-7163.MCT-12-0515. Epub 2012 Oct 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Urinary Bladder Neoplasms / drug therapy*
  • Urothelium / pathology*

Substances

  • Antineoplastic Agents